Fay Thoren Natasha's most recent trade in X4 Pharmaceuticals Inc was a trade of 3,333 Common Stock done . Disclosure was reported to the exchange on May 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| X4 Pharmaceuticals Inc | Fay Thoren Natasha | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 3,333 | 9,462 (0%) | 0% | 0 | Common Stock |